When.com Web Search

  1. Ads

    related to: can rosuvastatin cause weight loss or weight gain in women

Search results

  1. Results From The WOW.Com Content Network
  2. How to Reset These 10 Hormones That Affect Weight This Year - AOL

    www.aol.com/reset-10-hormones-affect-weight...

    How to Reset Female Hormones For Weight Loss. This article was reviewed by Craig Primack, MD, FACP, FAAP, MFOMA. Hormones can be helpful heroes, supporting the immune system and a healthy sleep ...

  3. Rosuvastatin - Wikipedia

    en.wikipedia.org/wiki/Rosuvastatin

    Rosuvastatin, sold under the brand name Crestor among others, is a statin medication, used to prevent cardiovascular disease in those at high risk and treat abnormal lipids. [6] It is recommended to be used together with dietary changes, exercise, and weight loss. [ 6 ]

  4. Prescriptions for weight loss drugs are skyrocketing ... - AOL

    www.aol.com/lifestyle/prescriptions-weight-loss...

    Weight-related health considerations unique to young women may also drive them to take GLP-1s. PCOS , which affects 7-10% of women between 18 and 44 in the U.S., including Sipes, is one of them.

  5. List of long term side effects of antipsychotics - Wikipedia

    en.wikipedia.org/wiki/List_of_long_term_side...

    Weight gain [18] There has been a study that suggests antipsychotics are associated with possible cortical reconfiguration and gray matter loss, [19] but correlational data also suggests patients who consume antipsychotics, like people with schizophrenia, tend to engage in unhealthy habits like smoking which may exacerbate gray matter loss. [20]

  6. The Health Risks and Benefits of Weight-Loss Drugs - AOL

    www.aol.com/health-risks-benefits-weight-loss...

    The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label that the drug can also reduce the risk of heart events by 20% in people with obesity , for example.

  7. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    As of 2022, there is no pathway for approval for drugs that reduce fat mass without 5 percent overall weight loss, even if they significantly improve metabolic health; neither is there one for drugs that help patients maintain weight loss although this can be more challenging than losing weight. [18]